APOE and Alzheimer disease: In Alzheimer’s disease (AD), impaired lipid metabolism contributes to Aβ aggregation and tau pathology, with cholesterol modulating APP processing and ApoE4 impairing Aβ clearance (Rajmohan and Reddy, 2017).